Lipoprotein(a), PCSK9 Inhibition and cardiovascular risk: Insights from the Fourier trial. (August 2018)

Record Type:: Journal Article
Title:: Lipoprotein(a), PCSK9 Inhibition and cardiovascular risk: Insights from the Fourier trial. (August 2018)
Main Title:: Lipoprotein(a), PCSK9 Inhibition and cardiovascular risk: Insights from the Fourier trial
Authors:: O'Donoghue, M.
Giugliano, R.
Keech, A.
Kanevsky, E.
Im, K.
Pineda, A.Lira
Somaratne, R.
Sever, P.
Pederson, T.
Sabatine, M.
Abstract:
Is Part Of:: Atherosclerosis. Volume 275(2018)
Journal:: Atherosclerosis
Issue:: Volume 275(2018)
Issue Display:: Volume 275, Issue 2018 (2018)
Year:: 2018
Volume:: 275
Issue:: 2018
Issue Sort Value:: 2018-0275-2018-0000
Page Start:: e9
Page End:: e10
Publication Date:: 2018-08
Subjects:: Arteriosclerosis -- Periodicals
Electronic journals
616.136
Journal URLs:: http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.atherosclerosis.2018.06.912 ↗
Languages:: English
ISSNs:: 0021-9150
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12831.xml